495 results on '"Gschwantler, Michael"'
Search Results
2. Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure
3. Prevalence and dynamics of NAFLD-associated fibrosis in people living with HIV in Vienna from first presentation to last follow-up
4. Ausbildung und Fortbildung in der Gastroenterologie und Hepatologie
5. Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV)
6. Diffuse idiopathic skeletal hyperostosis as a cause for dysphagia in a patient with ankylosing spondylitis
7. Diagnostik- und Therapieleitfaden 2023 für PBC in Österreich: Primär biliäre Cholangitis frühzeitig erkennen und risikostratifiziert behandeln
8. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
9. CHIME - A tailored HCV microelimination project in Viennese people who inject drugs at drug centralized substitution centers
10. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
11. HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease
12. Improvement of outcome prediction of hospitalized patients with COVID-19 by a dual marker strategy using high-sensitive cardiac troponin I and copeptin
13. Real-World Outcomes in Historically Underserved Patients with Chronic Hepatitis C Infection Treated with Glecaprevir/Pibrentasvir
14. Empfehlungen der ÖGGH zur Darmkrebsvorsorge und Nachsorge nach koloskopischer Polypektomie – Update 2021
15. Empfehlungen zur Abklärung der Hepatosplenomegalie bei Erwachsenen unter besonderer Berücksichtigung von lysosomalen Speichererkrankungen
16. Outcomes of an HCV elimination program targeting the Viennese MSM population
17. Eight Weeks of Treatment With Glecaprevir/Pibrentasvir Is Safe and Efficacious in an Integrated Analysis of Treatment-Naïve Patients With Hepatitis C Virus Infection
18. THU-380-YI Individualized intervals for streamlined directly observed therapy in PWIDs-a unique approach to continue HCV microelimination throughout the COVID19 pandemic
19. THU-390 Achieving HCV elimination in underserved populations-an austrian initiative for HCV care for homeless people without medical insurance
20. THU-381 Prognostic implications of liver stiffness impairment after HCV cure in cACLD patients
21. FRI-394 High burden of cirrhosis and increasing response rates to bulevirtide-based regimens: insights from the austrian prospective hepatitis D registry
22. Portal hypertension and its prognostic implications in patients with Wilson's disease
23. Direct patient-physician communication via a hepatitis C hotline facilitates treatment initiation in patients with poor adherence
24. Perceptions on the management of varices and on the use of albumin in patients with cirrhosis among GI specialists in Austria
25. Integrating public health policies in the epidemiological modeling of hepatitis C with LEHC tool: application in Austria
26. Correction to: Real-World Outcomes in Historically Underserved Patients with Chronic Hepatitis C Infection Treated with Glecaprevir/Pibrentasvir
27. Safety and efficacy of glecaprevir/pibrentasvir in patients with chronic hepatitis C genotypes 1–6 receiving opioid substitution therapy
28. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study
29. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
30. Burden of disease in patients with chronic hepatitis C in the Austrian REAL study
31. ELIMINATE: a PCR record-based macroelimination project for systematic recall of HCV-RNA-positive persons in Austria
32. Late-stage presentation with decompensated cirrhosis is alarmingly common but successful etiologic therapy allows for favorable clinical outcomes
33. Diaphragmatic perforation as a result of cystic echinococcosis in an HIV-positive migrant
34. Training and Continuing Medical Education in Gastroenterology and Hepatology
35. The risks of first hepatic decompensation and HCC remain constant during long-term follow-up and can be stratified by a one-time assessment after HCV-cure
36. Validation and refinement of the Baveno VII criteria for risk stratification in compensated advanced chronic liver disease after HCV-cure
37. Clinical features of portal hypertension and their prognostic implication in patients with Wilson’s disease
38. Efficacy of peginterferon plus ribavirin in patients receiving opioid substitution therapy: Final results of the Austrian PegHope study
39. Association of Interleukin-32 and Interleukin-34 with Cardiovascular Disease and Short-Term Mortality in COVID-19
40. Prevalence and dynamics of NAFLD-associated fibrosis in people living with HIV in Vienna from first presentation to last follow-up
41. Isolated peritoneal involvement as a primary manifestation of cystic echinococcosis
42. Efficacy of ledipasvir/sofosbuvir plus ribavirin for 12 weeks in patients with chronic hepatitis C genotype 3 and compensated liver disease
43. HCV hotline facilitates Hepatitis C elimination during the COVID ‐19 pandemic
44. The ‘Viennese epidemic’ of acute HCV in the era of direct-acting antivirals
45. Virologic response to bulevirtide is delayed in cirrhotic HDV patients with clinically significant portal hypertension
46. Response-guided long-term treatment of chronic hepatitis D patients with bulevirtide-Results of a “real world study”
47. Immediate-type hypersensitivity reaction to bulevirtide and successful desensitization in a patient with HBV/HDV-associated compensated cirrhosis
48. ELIMINATE-interim results of an Austrian HCV macro-elimination project
49. Bleeding Dieulafoy lesions of the small bowel: a systematic study on the epidemiology and efficacy of enteroscopic treatment
50. THU-166 Portal hypertension and its prognostic implications in patients with autoimmune hepatitis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.